Observational study investigating Tolerance Of Anticancer Systemic Therapy In the Elderly (TOASTIE): a protocol

• Sarah Taylor,
• Eleanor Smith,
• Christopher Mark Jones,
• Daniel Swinson,
• Mark A Baxter,
• Fiona Smith,
• R D Petty,
• Helen Dearden,
• Sally Martin,
• Michael Rowe,
• Kieran Zucker,
• Anna C Olsson-Brown,
• Clair Brunner,
• Anna Lewis,
• Lisa Rodgers,
• Anthea Cree

Affiliations

Sarah Taylor

Macmillan GP Lead for Early Diagnosis, Greater Manchester Strategic Health Authority, Manchester, UK

Eleanor Smith

Macmillan Palliative Care Unit, Northern General Hospital, Sheffield, UK

Christopher Mark Jones

Leeds Cancer Centre, St James’s University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK

Daniel Swinson

Leeds Cancer Centre, St James’s University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK

Mark A Baxter

Division of Molecular and Clinical Medicine, University of Dundee School of Medicine, Dundee, UK

Fiona Smith

Sue Ryder Care, Cheltenham, UK

R D Petty

Division of Molecular and Clinical Medicine, University of Dundee School of Medicine, Dundee, UK

Helen Dearden

Leeds Cancer Centre, St James’s University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK

Sally Martin

Leeds Cancer Centre, St James’s University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK

Michael Rowe

Plymouth Oncology Centre, Derriford Hospital Cancer Services Department, Plymouth, Plymouth, UK

Kieran Zucker

Leeds Cancer Centre, St James’s University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK

Anna C Olsson-Brown

Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, UK

Clair Brunner

Anna Lewis

Lisa Rodgers

Anthea Cree